CellWell record HH-398730
Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study
Moreno V; Bosch FX; Muñoz N; Meijer CJ; Shah KV; Walboomers JM; Herrero R; Franceschi S; International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group
Lancet (London, England) · 2002
In plain language
In women positive for HPV DNA, using oral contraceptives for 5 to 9 years or 10 or more years was associated with about 2.8 and 4.0 times higher odds of cervical cancer, respectively.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-398730
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.